Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1016/j.conctc.2020.100682 http://scihub22266oqcxt.onion/10.1016/j.conctc.2020.100682 33283069!7703225!33283069     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=33283069&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215       Contemp+Clin+Trials+Commun 2020 ; 20 (?): 100682 Nephropedia Template TP {{tp|p=33283069|t=2020. Risk and mitigation actions for clinical trials during COVID-19 pandemic (RiMiCOPa) |pdf=|usr=}}{{33283069}} gab.com Text Risk and mitigation actions for clinical trials during COVID-19 pandemic (RiMiCOPa) JO: Contemp Clin Trials Commun http://www.kidney.de/pget.php?&tw=1&pmid=33283069 #FOAvip The COVID-19 virus diffusion is, nowadays, global and any clinical trial is potentially affected by the direct and indirect consequences of the COVID-19 during the pandemic. Any step, from protocol design to result's disclosure, needs to be revised to assess the impact of the COVID-19 on the study, evaluate the potential risks, and establish a mitigation plan. We have developed a series of recommendations, belonging to our experience in any aspect of clinical trials. We hope that the Risk and Mitigation actions for clinical trials during COVID-19 Pandemic (RiMiCOPa) will help all clinical trial professionals, patients, auditors, and assessors to ensure effective data management, statistics, and medical writing standards while conducting clinical trials in the pandemic. Twit Text FOAVip Risk and mitigation actions for clinical trials during COVID-19 pandemic (RiMiCOPa) ????Contemp Clin Trials Commun http://www.kidney.de/pget.php?&tw=1&pmid=33283069 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33283069 #FOAvip English Wikipedia <ref>{{Cite pmid|33283069}}</ref> Risk and mitigation actions for clinical trials during COVID-19 pandemic (RiMiCOPa) #MMPMID33283069 Bacchieri A; Rossi A; Morelli P Contemp Clin Trials Commun 2020[Dec]; 20 (?): 100682 PMID33283069show ga The COVID-19 virus diffusion is, nowadays, global and any clinical trial is potentially affected by the direct and indirect consequences of the COVID-19 during the pandemic. Any step, from protocol design to result's disclosure, needs to be revised to assess the impact of the COVID-19 on the study, evaluate the potential risks, and establish a mitigation plan. We have developed a series of recommendations, belonging to our experience in any aspect of clinical trials. We hope that the Risk and Mitigation actions for clinical trials during COVID-19 Pandemic (RiMiCOPa) will help all clinical trial professionals, patients, auditors, and assessors to ensure effective data management, statistics, and medical writing standards while conducting clinical trials in the pandemic. ?Risk and mitigation actions for clinical trials during COVID-19 pandem(epmc).pdf DeepDyve Pubget Overpricing